Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
16 November 2023
PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
2 November 2023
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
2 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
30 October 2023
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Researchers analyse UK COVID-19 Infection Survey data to tell the story of the virus' genomic evolution and spread
18 October 2023
Research published today brings together for the first time the epidemiology and evolution of the SARS-CoV-2 virus in the UK during the first three years of the pandemic – including how variants emerged and spread.
Conference brings together clinical researchers to explore lessons from COVID-19 for global research collaboration
16 October 2023
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
10 October 2023
The University of Oxford has launched a new global vaccine collaboration, backed by £8 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
5 October 2023
Professor Dame Sarah Gilbert, the Oxford Project Leader for the Oxford-AstraZeneca COVID-19 vaccine and Pandemic Sciences Institute researcher, has received the Freedom of the City of London in recognition of her outstanding achievements in, and contribution to, science and public health.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
18 September 2023
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
11 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
30 August 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
26 July 2023
PSI and the WHO Hub for Pandemic and Epidemic Intelligence will collaborate to improve the detection and tracking of infectious diseases.
7 July 2023
Representatives from academia, industry, policy and civil society are gathering in Oxford next week to discuss the latest scientific advances that are ensuring the world is better prepared for future pandemics.
14 June 2023
PSI Director Professor Sir Peter Horby today gave evidence at the House of Commons’ Science, Innovation and Technology Select Committee Inquiry on Emerging Diseases and Learnings from COVID-19.
28 April 2023
Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
13 April 2023
Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.
11 April 2023
A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
31 March 2023
Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.